PBS listing – Ferro-Tabs

AFT Pharmaceuticals is pleased to announce that from 01 September 2011 it’s iron replacement product Ferro-Tabs will be PBS Listed.

“This will make iron replacement therapy more readily available for groups in need such as indigenous peoples or the elderly and will assist in the implementation of the recommendations made by the National Iron Deficiency Anaemia expert groups,” said Group CEO, Dr Hartley Atkinson.

November 20, 2025

AFT delivers 10th consecutive first half revenue increase

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…

Read More

November 12, 2025

AFT Pharmaceuticals Brings Next-Generation Liposomal Collagen and Wellness Range to the U.S. Market 

AFT Pharmaceuticals has launched its full Lipo-Sachets® range in the U.S., featuring advanced collagen and vitamin supplements powered by patented LI…

Read More

September 25, 2025

On track for $300m FY27 revenue; positive iron IV study result

– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …

Read More